Data & APIsEventsMarketfyPremarketBoost
Contribute Login Join
Data & APIs
Events
Marketfy
Premarket
Boost

Debanjan Ray Net Worth & Insider Trades

Debanjan Ray - Chief Financial Officer, Cytomx Therapeutics, Inc

As of January 29, 2019

What is Debanjan Ray's Net Worth?

The current estimated net worth of Cytomx Therapeutics, Inc's Chief Financial Officer, Debanjan Ray, is estimated to be about $1.98M . Debanjan Ray owns about 5,928 units of Cytomx Therapeutics, Inc common stock. In the last 2 years at Cytomx Therapeutics, Inc, Debanjan Ray has sold an estimated value of $1.98M worth.

What is Debanjan Ray's Past Insider Trading?

Debanjan Ray's largest purchase order was 33,000 units , worth over $39.75K on March 5, 2018. Debanjan Ray's largest sale order was 33,000 units , worth over $989.69K on March 5, 2018. In total, Debanjan Ray has made about 21 transactions over 2 years of their time at Cytomx Therapeutics, Inc. Debanjan Ray usually trades in January, with the busiest year in 2018. The most recent transaction was a sale order of 3,000 units , worth over $45K on December 14, 2018.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Debanjan Ray

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

InsideArbitrage

Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What is Debanjan Ray's' Mailing Address?

  • Mailing address is C/o Cytomx Therapeutics, Inc. 151 Oyster Point Blvd, Suite 400 South San Francisco CA 94080 CA

What are Cytomx Therapeutics, Inc's Past Insider Trades?

Cytomx Therapeutics, Inc's most recent insider trade came on September 22, 2023 by Marcia Belvin who sold 4,119 units worth $5.36K . In the last 8 years, insiders at Cytomx Therapeutics, Inc have sold an estimated value of $57.65M and bought an estimated value of $10.3M worth of shares. Insider trading is most common in June, with the busiest year in 2017. The most active traders at the company are Sean A McCarthy, CEO,  Debanjan Ray, Chief Financial Officer,  and Canaan Ix Lp, Director .

CytomX Therapeutics, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...